The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2022
Filed:
Dec. 18, 2017
Applicants:
Medimmune Limited, Cambridge, GB;
Fundacio Privada Institut D'investigacio Oncologica DE Vall Hebron, Barcelona, ES;
Fundacio Privada Institucio Catalana DE Recerca I Estudis Avancats, Barcelona, ES;
Inventors:
Joan Seoane Suarez, Barcelona, ES;
Judit Anido Folgueira, Barcelona, ES;
Johan Fransson, Toronto, CA;
Jean-Philippe Julien, Toronto, CA;
Swetha Raman, Toronto, CA;
Assignees:
MEDIMMUNE LIMITED, Cambridge, GB;
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGIC, Barcelona, ES;
FUNDACIO PRIVADA INSTITUCIO CATALANA DE RECERCA I, Barcelona, ES;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 14/54 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/395 (2013.01); A61P 35/00 (2018.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.